Expanding the Therapeutic Horizons of Psilocybin in Mental Health
ACS Medicinal Chemistry Letters October 15, 2024 DOI: 10.1021/acsmedchemlett.4c00488 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | Psilocybin |
| Topics | Psilocybin |
| Keywords | New horizons Hallucinogen Mental health Data science |
| Citations | 1 |
| Key findings | Psilocybin demonstrates versatility and potential to reshape mental health treatment through personalized medicine and accessible wellness applications. |
Abstract
Psilocybin, a naturally occurring psychedelic compound, has recently emerged as a promising therapeutic agent for mental health. This Patent Highlight explores the innovative approaches to harnessing psilocybin's potential across various contexts. These include clinical trials targeting severe psychiatric conditions, the integration of low-dose psilocybin into dietary products to promote general mental well-being, and the personalization of psilocybin dosing for optimal treatment of depression and anxiety. These advancements demonstrate psilocybin's versatility and potential to reshape conventional mental health treatment paradigms, mainly through personalized medicine and accessible wellness applications.